These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24937691)

  • 41. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
    Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
    J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
    Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
    Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
    Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up.
    Brennan SB; Sung JS; Dershaw DD; Liberman L; Morris EA
    Radiology; 2011 Oct; 261(1):92-9. PubMed ID: 21852565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
    Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
    Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.
    Wahlen MM; Lizarraga IM; Kahl AR; Zahnd WE; Eberth JM; Overholser L; Askelson N; Hirschey R; Yeager K; Nash S; Engelbart JM; Charlton ME
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):171-186. PubMed ID: 37095280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
    Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
    Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer.
    Girardi V; Carbognin G; Camera L; Baglio I; Bucci A; Bonetti F; Mucelli RP
    Radiol Med; 2011 Dec; 116(8):1226-38. PubMed ID: 21744256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk-to-Benefit Relationship of Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies with Immediate Reconstruction.
    Alba B; Schultz BD; Cohen D; Qin AL; Chan W; Tanna N
    Plast Reconstr Surg; 2019 Jul; 144(1):1-9. PubMed ID: 31246789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
    Bedrosian I; Hu CY; Chang GJ
    J Natl Cancer Inst; 2010 Mar; 102(6):401-9. PubMed ID: 20185801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.
    Rutter CE; Park HS; Killelea BK; Evans SB
    Ann Surg Oncol; 2015 Jul; 22(7):2378-86. PubMed ID: 25564175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.
    Parker PA; Peterson SK; Shen Y; Bedrosian I; Black DM; Thompson AM; Nelson JC; DeSnyder SM; Cook RL; Hunt KK; Volk RJ; Cantor SB; Dong W; Brewster AM
    J Clin Oncol; 2018 Sep; 36(25):2630-2638. PubMed ID: 30044695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.